Completed PHASE3 INTERVENTIONAL 2-arm NCT04756804

Perioperative Patient Skin Antiseptic Preparation Evaluation

A Randomized, Controlled Clinical Trial Evaluating A Novel Perioperative Patient Skin Antiseptic Preparation

Sponsor: Zurex Pharma, Inc.

Interventions 2%w/v Chlorhexidine Gluconate / 70% v/v Isopropyl Alcohol 70% v/v Isopropyl Alcohol Surgical Solution

Updated 9 times since 2021 Last updated: Feb 20, 2024 Started: Jun 21, 2021 Primary completion: Sep 29, 2022 Completion: Sep 29, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Surgical Site Infection, this trial is completed. The trial is conducted by Zurex Pharma, Inc. and has accumulated 9 data snapshots since 2021. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Apr 2024 — Jul 2024 [monthly]

Completed PHASE3
Feb 2023 — Apr 2024 [monthly]

Completed PHASE3

Status: Recruiting → Completed
Apr 2022 — Feb 2023 [monthly]

Recruiting PHASE3

▶ Show 4 earlier versions

Nov 2021 — Apr 2022 [monthly]

Recruiting PHASE3
Sep 2021 — Nov 2021 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Jun 2021 — Sep 2021 [monthly]

Not Yet Recruiting PHASE3
Mar 2021 — Jun 2021 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zurex Pharma, Inc.

Data source: Zurex Pharma, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milwaukee, United States